|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,630.20 INR | +3.14% |
|
+3.03% | +22.65% |
| Market Cap | 232B 2.45B 2.15B 1.98B 1.85B 3.48B 3.56B 23.84B 9.2B 114B 9.21B 9B 397B | P/E 2026 |
42.3x | P/E 2027 * | 55.3x |
|---|---|---|---|---|---|
| Enterprise Value | 232B 2.45B 2.15B 1.98B 1.85B 3.48B 3.56B 23.83B 9.2B 114B 9.2B 9B 397B | EV / Sales 2026 |
7.59x | EV / Sales 2027 * | 9.8x |
| Free-Float |
62.24% | Yield 2026 |
0.28% | Yield 2027 * | 0.08% |
Last Transcript: Neuland Laboratories Limited
| 1 day | +3.14% | ||
| 1 week | +3.03% | ||
| Current month | +9.15% | ||
| 1 month | +8.44% | ||
| 3 months | +55.09% | ||
| 6 months | +24.57% | ||
| Current year | +22.65% |
| 1 week | 17,610 |  | 18,770 |
| 1 month | 16,478.45 | | 18,770 |
| Current year | 11,500 | | 18,770 |
| 1 year | 11,500 | | 19,748.4 |
| 3 years | 2,799.8 | | 19,748.4 |
| 5 years | 965.85 | | 19,748.4 |
| 10 years | 247.3 | | 19,748.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 01/01/2002 | |
| Chairman | 82 | 07/01/1984 | |
| Director/Board Member | 46 | 01/03/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.14% | +3.03% | +55.17% | +558.16% | 2.45B | |
| +1.81% | +11.60% | +58.61% | +164.79% | 1,097B | |
| +1.51% | +11.77% | +69.61% | +57.53% | 622B | |
| +0.38% | +10.56% | +39.49% | +90.88% | 449B | |
| -0.90% | +6.34% | +29.51% | +24.01% | 334B | |
| +1.09% | +6.74% | +43.34% | +28.64% | 294B | |
| +1.06% | +3.40% | +32.70% | +41.80% | 286B | |
| +1.31% | +3.70% | -27.40% | -41.94% | 213B | |
| +0.62% | +4.59% | +30.10% | +63.03% | 195B | |
| -1.21% | +1.17% | +14.15% | +66.20% | 157B | |
| Average | +0.39% | +6.61% | +34.53% | +105.31% | 364.92B | |
| Weighted average by Cap. | +0.08% | +8.72% | +43.75% | +82.44% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 17.64B 187M 163M 151M 141M 265M 271M 1.81B 701M 8.7B 701M 685M 30.21B | 23.33B 247M 216M 199M 186M 351M 359M 2.4B 927M 11.51B 927M 906M 39.96B |
| Net income | 2.57B 27.21M 23.83M 22M 20.54M 38.67M 39.55M 265M 102M 1.27B 102M 99.95M 4.41B | 4.21B 44.52M 38.98M 35.99M 33.61M 63.26M 64.7M 433M 167M 2.08B 167M 164M 7.21B |
| Net Debt | -117M -1.23M -1.08M -996K -930K -1.75M -1.79M -11.99M -4.63M -57.48M -4.63M -4.53M -200M | -3.18B -33.68M -29.49M -27.23M -25.43M -47.86M -48.95M -328M -126M -1.57B -126M -124M -5.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | ₹18,630.20 | +3.14% | 1,350 |
| 29/06/26 | ₹18,062.80 | +0.70% | 982 |
| 25/06/26 | ₹17,937.60 | -0.69% | 792 |
| 24/06/26 | ₹18,062.40 | -0.11% | 4,773 |
| 23/06/26 | ₹18,082.15 | +5.12% | 3,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions
